2016 was not a good year for new medicines. The U.S. Food and Drug Administration cleared just 22 new drugs for sale last year, the lowest number since 2010 and a sharp decline from 2015's total of 45 approved drugs. While the FDA simply delayed approval on some applications that will likely be given the green light in 2017, there's also been a decline in applications overall, Reuters reports. Despite recent advances in cancer treatment and other genetic diseases, drug companies are finding difficulty securing financial returns due to political pushback against the rising costs of medicine. Returns on research and development investment at the top 12 pharmaceutical companies fell to 3.7 percent in 2016, from a high of 10.1 percent in 2010.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Heated Rivalry, Bridgerton and why sex still sells on TVTalking Point Gen Z – often stereotyped as prudish and puritanical – are attracted to authenticity
-
Sean Bean brings ‘charisma’ and warmth to Get BirdingThe Week Recommends Surprise new host of RSPB’s birdwatching podcast is a hit
-
Film reviews: ‘Send Help’ and ‘Private Life’Feature An office doormat is stranded alone with her awful boss and a frazzled therapist turns amateur murder investigator
-
TikTok secures deal to remain in USSpeed Read ByteDance will form a US version of the popular video-sharing platform
-
Unemployment rate ticks up amid fall job lossesSpeed Read Data released by the Commerce Department indicates ‘one of the weakest American labor markets in years’
-
US mints final penny after 232-year runSpeed Read Production of the one-cent coin has ended
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
